FDA Pulls Emergency Use of Trump’s COVID-19 ‘Game Changer’ Hydroxychloroquine

The Food and Drug Administration (FDA) announced it is pulling the emergency use of the anti-malaria drugs, chloroquine and hydroxychloroquine, for COVID-19.

President Donald Trump claimed in May that he was taking hydroxychloroquine to prevent infection from the coronavirus, but White House physician Dr. Sean Conley did not confirm anything more than a discussion took place.

The FDA ruled that chloroquine (CQ) and hydroxychloroquine (HCQ) are “unlikely to be effective in treating COVID-19 for the authorized uses in the EUA,” noted CNBC:

Additionally, in light of ongoing serious cardiac adverse events and other serious side effects, the known and potential benefits of CQ and HCQ no longer outweigh the known and potential risks for the authorized use.

The FDA issued the emergency use authorization for chloroquine and hydroxychloroquine in March, but warned in April about using the drugs outside a hospital or a formal clinical trial due to the risk of “serious heart rhythm problems.”

(Sources: CNBC, Fox News via Twitter)

About The Author

You might be interested in

LEAVE YOUR COMMENT

Your email address will not be published. Required fields are marked *

Get The Latest News Videos Before Everyone Else!

Get The Latest News Videos Before Everyone Else!

Subscribe to our Newsletter for Free (Really!)

You have Successfully Subscribed!